Navigation Links
Adeona Reports Third Quarter 2011 Financial Results
Date:11/14/2011

ANN ARBOR, Mich., Nov. 14, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (AMEX: AEN), a developer of innovative medicines for serious central nervous system diseases, today reported its third quarter 2011 financial results for the period ended September 30, 2011, as well as updates since the beginning of the third quarter.

Updates since the beginning of the third quarter include:

Drug Development Programs

Relapsing-Remitting Multiple Sclerosis (MS)

  • As of September 19, 2011, the 150th patient was enrolled in the clinical trial evaluating Trimesta™ (oral estriol) in women suffering from relapsing-remitting MS, per the original protocol.

  • The Lead Principal Investigator, Rhonda Voskuhl, M.D., Director, University of California, Los Angeles (UCLA) Multiple Sclerosis Program, Department of Neurology, is using grant funding to continue enrollment of an additional 10-20 patients at all 15 centers in the United States.

Cognitive Dysfunction in MS

  • On November 11, 2011, we announced that our drug candidate, Trimesta, will be utilized in a new randomized, double-blind, placebo-controlled Phase II clinical trial to evaluate its potential therapeutic effect on cognitive dysfunction in women suffering from MS, a major consequence of this disease.

  • We and the Skirball Foundation have pledged to equally support this clinical trial led by Dr. Voskuhl. The study, which focuses on cognition dysfunction in MS patients, also received financial support from the Sherak Family Fund, the Gustafson Fund, and the Diamont family.

Fibromyalgia

  • In May 2010, we announced a $17.5 million c
    '/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research
2. Adeona Senior Vice President of Research & Development to Present at American College of Nutrition Annual Meeting
3. Adeona Appoints Jeff Lucero Riley as Independent Chairman
4. Adeonas Planned Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease is Hot Topic at 2011 California ALS Research Summit
5. Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial
6. Adeona Appoints George A. Eby to Scientific Advisory Board
7. Adeona Reports Second Quarter 2011 Financial Results
8. Adeona to Host Second Quarter 2011 Investor Conference Call
9. Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease (ALS)
10. Adeona Reports 1st Quarter 2011 Financial Results
11. Adeona to Host First Quarter 2011 Investor Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 2014 After 6 months of careful ... here - the new programme for the next Cool Chain ... our global Cool Chain series, has just been released! ... As the lines between supply chain, logistics, QA and ... that is broad and yet specific, focused and yet accessible, ...
(Date:9/18/2014)... Calif. , Sept. 18, 2014   ... ), a biopharmaceutical company leading the discovery and ... it has initiated its ATHENA natural history of ... life-threatening genetic kidney disease with no approved therapy. ... natural decline of renal function markers such as ...
(Date:9/18/2014)... , Sept. 18, 2014  RXi Pharmaceuticals ... biotechnology company focused on discovering, developing and ... needs using RNA-targeted technologies, today announced that the ... Geert Cauwenbergh , will present at ... Conference on Wednesday, September 24, 2014 at ...
Breaking Medicine Technology:Europe's Biggest and Longest-Running Gathering of Life Sciences Logistics, Supply Chain & QA Professionals 2Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 2Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 3Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 4Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 5Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 6RXi Pharmaceuticals to Present at the 7th Annual BioPharm America Conference 2RXi Pharmaceuticals to Present at the 7th Annual BioPharm America Conference 3
... MADISON, N.J., March 28, 2011 Quest Diagnostics Incorporated ... of diagnostic testing, information and services, announced today it ... subsidiary, Spark Acquisition Corporation, for all of the outstanding ... (Nasdaq: CRA ), one of the world,s ...
... (Nasdaq: VRUS ) today announced that it will ... Study of the Liver (EASL) on Saturday, April 2, 2011 ... Pharmasset,s progress on the programs that are the subject of ... a simultaneous webcast of this event via the internet, log ...
Cached Medicine Technology:Quest Diagnostics Commences Tender Offer for Acquisition of Celera 2Quest Diagnostics Commences Tender Offer for Acquisition of Celera 3Pharmasset to Webcast an Investor Event From the EASL Meeting 2Pharmasset to Webcast an Investor Event From the EASL Meeting 3
(Date:9/18/2014)... PA (PRWEB) September 18, 2014 ... announces the launch of Good Neighbor Pharmacy University, ... access information that will educate and empower pharmacy ... “As the healthcare industry continues to evolve, Good ... as we deliver resources and tools to help ...
(Date:9/18/2014)... London. (PRWEB) September 18, 2014 CD-adapco, ... Aided Engineering software, today announced its new partnership with ... utilizing the CD-adapco simulation tool, STAR-CCM+® in the design ... announced its participation in the 35th America’s Cup taking ... edition of the America’s Cup is sustainability, the set ...
(Date:9/18/2014)... of college-educated parents eat more vegetables and drink less ... of British Columbia. But it,s still not enough, the ... falling short when it comes to eating healthier at ... an indicator of socioeconomic status, may inform a child,s ... parents completed some post-secondary education were 85 per cent ...
(Date:9/18/2014)... German . ... won the ,International Space Station Research Competition, with their ... the scientists will see the International Space Station crew ... crystallizing two proteins of the hepatitis C virus under ... International Space Station is scheduled to lift off from ...
(Date:9/18/2014)... Cary, NC (PRWEB) September 18, 2014 Relias ... the health and human services markets, today announced it has ... the fastest growing private companies in America. , In the ... growth, and moved up almost 2,000 spots on the Inc. ... in 2012. , “The industries we serve continue ...
Breaking Medicine News(10 mins):Health News:Good Neighbor Pharmacy University Keeps Pharmacists Ahead of the Curve 2Health News:Ben Ainslie Racing Using STAR-CCM+ Simulation Software to Design 35th America’s Cup Racing Boat 2Health News:Kids eat better if their parents went to college 2Health News:Hepatitis C virus proteins in space 2Health News:Relias Learning Named to Inc. 5000 List for Second Consecutive Year 2
... WASHINGTON, Sept. 26 HHS Secretary Mike,Leavitt today announced ... eligible low income homeowners and renters meet home energy ... are expected to,provide states with heating assistance for the ... from the cold," Secretary Leavitt said. "These,funds will put ...
... Committee of,Massachusetts (AAC) today presented written and oral testimony ... of bills having to do with privacy,informed consent and ... in support of H2276,the Public Health Privacy Act, urging ... the public health system,s interest in obtaining health,information for ...
... SAN DIEGO and MCLEAN, Va., Sept. 26 ... today that it,has won a new $38 million ... the,Theater Medical Information Program -- Joint (TMIP-J). ... base,period of performance and three one-year options. The ...
... Sept. 26 SEIU United Healthcare,Workers-West and ... relief seeking,to stop Tenet Healthcare Corp. from ... employees, including registered nurses,pharmacists, licensed vocational nurses, ... certified nursing,assistants. Workers represented by the ...
... of its ongoing dedication to,serving military members and their ... sponsor of Fleet Week San Diego, a,month-long celebration of ... its 11th year on Sept. 17 and continues until,Oct. ... historical, economic and,cultural importance of military personnel in San ...
... Residents from Metropolitan,Jewish Geriatric Center recently participated in ... Yom Kippur. (Photo: http://www.newscom.com/cgi-bin/prnh/20070926/NYW148 ) ... (a rooster for a man and a,hen for ... while reciting a prayer.,This ritual is meant to ...
Cached Medicine News:Health News:HHS Provides Over $131 Million In Energy Assistance 2Health News:AIDS Action Committee Testifies to Protect the Privacy of People Seeking Healthcare in Massachusetts 2Health News:SAIC Selected to Support the U.S. Military Theater Medical Information Program-Joint 2Health News:Unions File Charges Against Tenet Healthcare Corporation, Three Northern California Hospitals 2Health News:TriWest On Deck to Support Fleet Week San Diego 2
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... TOX/See™ is a 1-step, hand-held, point-of-care device ... metabolites in human urine. The TOX/See device ... commonly abused drugs in 3 to 8 minutes ... Each TOX/See cassette is individually packaged to maximize ...
... TOX/See™ is a 1-step, hand-held, point-of-care device ... metabolites in human urine. The TOX/See device ... commonly abused drugs in 3 to 8 minutes ... Each TOX/See cassette is individually packaged to maximize ...
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
Medicine Products: